Total Payments
$4,653
2024 Payments
$693.69
Companies
27
Transactions
179
Medicare Patients
1,185
Medicare Billing
$145,247
Payment Breakdown by Category
Food & Beverage$3,632 (78.1%)
Travel$1,021 (21.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,632 | 177 | 78.1% |
| Travel and Lodging | $1,021 | 2 | 21.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,516 | 20 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $519.31 | 33 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $406.33 | 28 | $0 (2022) |
| Abbott Laboratories | $243.84 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $216.34 | 3 | $0 (2019) |
| Amgen Inc. | $193.36 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $183.49 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $174.25 | 12 | $0 (2023) |
| Chiesi USA, Inc. | $156.91 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $146.02 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $693.69 | 36 | Merck Sharp & Dohme LLC ($183.49) |
| 2023 | $205.34 | 12 | Novartis Pharmaceuticals Corporation ($72.18) |
| 2022 | $327.35 | 9 | Abbott Laboratories ($229.64) |
| 2021 | $41.12 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($24.84) |
| 2020 | $259.71 | 16 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($60.88) |
| 2019 | $734.57 | 38 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($101.54) |
| 2018 | $666.53 | 40 | Novartis Pharmaceuticals Corporation ($203.06) |
| 2017 | $1,725 | 25 | Medtronic Vascular, Inc. ($1,359) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.46 | General |
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.68 | General |
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 05/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: DIABETES | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $27.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 26 | 26 | $23,517 | $5,011 |
| 2022 | 11 | 325 | 554 | $76,495 | $33,033 |
| 2021 | 8 | 387 | 745 | $92,484 | $54,040 |
| 2020 | 10 | 447 | 786 | $112,555 | $53,163 |
Total Patients
1,185
Total Services
2,111
Medicare Billing
$145,247
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $23,517 | $5,011 | 21.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 198 | $20,630 | $11,366 | 55.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 27 | $7,785 | $4,082 | 52.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 57 | $7,678 | $3,715 | 48.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 50 | 83 | $7,040 | $2,513 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $5,042 | $2,393 | 47.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 13 | 13 | $11,772 | $2,259 | 19.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 27 | 27 | $5,448 | $2,148 | 39.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 20 | $4,095 | $1,983 | 48.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 24 | 24 | $4,444 | $1,238 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 18 | $1,512 | $892.44 | 59.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 38 | 70 | $1,050 | $444.07 | 42.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 123 | 371 | $37,100 | $21,754 | 58.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 86 | 97 | $25,511 | $15,981 | 62.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 87 | $11,653 | $6,921 | 59.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 26 | 26 | $7,479 | $3,636 | 48.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 22 | $3,894 | $2,473 | 63.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 34 | 55 | $3,300 | $1,735 | 52.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 16 | 19 | $2,527 | $1,092 | 43.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 39 | 68 | $1,020 | $446.55 | 43.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 128 | 382 | $42,540 | $22,905 | 53.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 76 | 79 | $18,874 | $9,076 | 48.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 43 | 46 | $12,377 | $7,738 | 62.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 52 | 109 | $9,380 | $3,601 | 38.4% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart | Facility | 2020 | 17 | 18 | $9,371 | $3,571 | 38.1% |
About Dr. Nitin Gupta, MD
Dr. Nitin Gupta, MD is a Interventional Cardiology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568620003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nitin Gupta, MD has received a total of $4,653 in payments from pharmaceutical and medical device companies, with $693.69 received in 2024. These payments were reported across 179 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,632).
As a Medicare-enrolled provider, Gupta has provided services to 1,185 Medicare beneficiaries, totaling 2,111 services with total Medicare billing of $145,247. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Southfield, MI
- Active Since 05/31/2008
- Last Updated 09/21/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1568620003
Products in Payments
- VenaSeal (Device) $1,317
- LifeVest (Device) $406.33
- ENTRESTO (Drug) $293.09
- LEQVIO (Drug) $226.22
- PRALUENT (Drug) $216.34
- VERQUVO (Drug) $183.49
- PRESSUREWIRE (Device) $177.04
- KENGREAL (Drug) $156.91
- ELIQUIS (Drug) $156.65
- Corlanor (Drug) $152.98
- XARELTO (Drug) $145.61
- JARDIANCE (Drug) $131.04
- DALVANCE (Drug) $84.03
- Azure (Device) $71.77
- FARXIGA (Drug) $64.82
- SYNERGY (Device) $60.65
- CARDIOMEMS (Device) $52.60
- Inpefa (Drug) $52.30
- BRILINTA (Drug) $51.18
- Claria MRI (Device) $34.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.